- Home
- QCLS vs ICCM Comparison
QCLS vs ICCM Comparison
Compare QCLS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QCLS | ICCM |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 8.3M |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | QCLS | ICCM |
|---|---|---|
| Price | $0.63 | $1.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | ★ 6.1M | 162.7K |
| Earning Date | 11-18-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,929,527.00 | N/A |
| Revenue This Year | N/A | $34.08 |
| Revenue Next Year | N/A | $94.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.71 | N/A |
| 52 Week Low | $0.42 | $0.13 |
| 52 Week High | $8.17 | $9.54 |
Technical Indicators
Market Signals| Indicator | QCLS | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 28.33 | 15.84 |
| Support Level | $0.42 | $0.22 |
| Resistance Level | $1.18 | $2.50 |
| Average True Range (ATR) | 0.12 | 0.19 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 4.16 | 3.00 |
Price Performance
Historical ComparisonAbout QCLS Q/C Technologies Inc.
Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.